Title
|
Published
|
Price
|
|
3G Bulletin
By: Visiongain
The 3G market is begining to take shape, but significant changes are happening every 4 weeks. Normal mangement reports are too slow and magazines don't give you the information that counts. Wouldn't it be perfect
|
more...
|
1/1/2000
|
$1,118.40
|
|
3rd Generation Report 2001
By: Visiongain
This vital industry report is designed to help you react NOW to the challenges that will be presented by the 3G market. Ensure YOU keep up-to speed about Who's doing what, Why they re doing
|
more...
|
4/15/2000
|
$2,078.40
|
|
Achieving Success In The Developing Asian Pharmaceutical Sector 2007-2011
By: Visiongain
Will the economic growth in new Asian markets allow you to offset global problems? With the Japan market slow and stagnant what other countries in the region offer you the greatest opportunities and how can
|
more...
|
11/9/2006
|
$2,210.00
|
|
Ad Funded Mobile Content: Forecasts and Analysis 2008
By: Visiongain
Mobile content is evolving. What was previously expensive and difficult to obtain is now becoming accessible to a large section of the mobile audience. Mobile content has been driven to the mobile audience in a
|
more...
|
7/24/2008
|
$5,006.00
|
|
Alzheimer's Disease Market Analysis and Forecasts, 2007-2012, 2017 &
By: Visiongain
Alzheimers disease (AD) is the third leading cause of death in recent times and with an unprecedented patient potential, this disease area attracts awareness from a broad base of stake holders. With the grey population
|
more...
|
10/15/2007
|
$2,210.00
|
|
AMD Market Outlook to 2012
By: Visiongain
AMD is the most common cause of vision loss in the developed world for those over 50 years of age. We estimate there are over 20 million cases in the US and Europe. Dry AMD
|
more...
|
3/16/2007
|
$2,210.00
|
|
Anti-addiction Therapies, 2006-2011 - The Pharmaceutical Industry’s Next Viagra?
By: Visiongain
More money is spent advertising alcohol than any other product. For some, it like gambling and cigerettes are pleasant distractions, yet for others they are the generators of unbearable cravings and the cause of considerable
|
more...
|
10/19/2006
|
$2,210.00
|
|
Anti-Infectives 2002
By: Visiongain
The leading Anti-Infectives report of 2002- available today
Over 350 pages FULL of graphs, charts & analysis - you cannot afford to ignore this report.
If you require 1 leading source of Anti-Infectives information -
|
more...
|
9/1/2002
|
$3,518.00
|
|
Anti-Obesity Treatments 2007-2012 - A blockbuster target market
By: Visiongain
“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, researcher has found”. For pharmaceutical companies looking to target growing successful markets,
|
more...
|
7/13/2007
|
$2,210.00
|
|
Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
By: Visiongain
Obesity has been described as a 'public health time-bomb'. In 2005, the World Health Organization estimated that approximately 400 million individuals are obese. Prevalence of obesity is rising worryingly in many countries, despite campaigns emphasizing
|
more...
|
2/23/2009
|
$2,502.00
|
|
Apple in Mobile
By: Visiongain
Apple Inc has made its name in providing consumer electronics and demonstrating brand strength and recognisability among a variety of computer products. After making a large impact in the music player market with the Apple
|
more...
|
1/21/2009
|
$2,502.00
|
|
Apple in Wireless: Strategic Options in a Converged Marketplace
By: Visiongain
The success of the iPod has redefined several markets, namely the MP3 player and digital content markets, as well as revitalised the Apple brand itself. This may in turn disrupt the computing and convergence landscape.
|
more...
|
4/18/2006
|
$2,210.00
|
|
Apple's iPhone & Mobile Report 2009: Competing successfully with Devices, Content & Services from Apple
By: Visiongain
Having long harboured ambitions to enter the mobile space, Apple has blazed a convincing trail through the market across the mobile board, i.e. devices, content and services. After upgrading the iPhone's network connectivity fom EDGE
|
more...
|
4/2/2009
|
$2,502.00
|
|
Billing in Convergence: Analysing the Next-Generation Billing Market
By: Visiongain
How to ensure you do not lose money with convergence
Good billing practices are critical for the success of any business, and billing is set to gain an even more important role in telecoms,
|
more...
|
12/1/2005
|
$2,210.00
|
|
Biogenerics 2006: Challenges Ahead For An Emerging Market
By: Visiongain
The world biogenerics market is about to develop on a very large scale. The approval of generic growth hormones in the US and Europe has finally occurred and this has created a new source of
|
more...
|
6/14/2006
|
$2,210.00
|
|
Bioinformatics Report - The Forecasts and Future of The Market 2006-2011
By: Visiongain
"Outsourcing defines future of Euro Bioinformatics market"
"Jump on bioinformatics bandwagon"
These are just two newspaper headlines that appeared today. Managing your data is critical to your organisation. You already know that. But is
|
more...
|
10/26/2006
|
$2,210.00
|
|
Bioinformatics Report 2003 - 3rd Edition
By: Visiongain
The forecast value for the worldwide bioinformatics market will be
approximately $7 billion by 2007. Biotechnology and pharmaceutical companies
are set to continue the recent trend of purchasing content and informatic
solutions from commercial vendors.
|
more...
|
2/1/2003
|
$3,271.76
|
|
Biometrics for Defence 2008
By: Visiongain
Biometrics refers to automated identification methods using unique human identifiers such as fingerprints and iris and facial patterns. Biometrics, regarded as a sophisticated means for identity management, is useful not only for securing airports and
|
more...
|
8/8/2008
|
$2,150.00
|
|
Biometrics for Defence Analysis 2008
By: Visiongain
Biometrics refers to automated identification methods using unique human identifiers such as fingerprints and iris and facial patterns. Biometrics, regarded as a sophisticated means for identity management, is useful not only for securing airports and
|
more...
|
8/8/2008
|
$2,169.00
|
|
Biometrics for Homeland Security Analysis & Forecasts 2008-2018
By: Visiongain
The September 11, 2001, terrorist attacks in the United States and later bombings in Madrid in 2004 and London in 2005 have made it imperative for countries worldwide to tighten national security. These security measures
|
more...
|
9/19/2008
|
$2,169.00
|
|
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
By: Visiongain
There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success - our new report explains how
Revenues for biologic drugs reached approximately $125bn in
|
more...
|
4/16/2009
|
$2,502.00
|
|
Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
By: Visiongain
The two major problems for biotech drugs are their mode of delivery and relative instability. The majority of delivery methods for biological drugs involve injection, which is not necessarily ideal for most indications. As the
|
more...
|
2/19/2007
|
$2,210.00
|
|
Blockbuster Drugs - Create, Develop and Market a Billion Dollar Drug
By: Visiongain
In 1992 only 4 Blockbuster drugs existed. The number jumped in 1998 to
29 and again in 2000 to 55. What is it now? This report will tell you.
In 1991, Blockbusters accounted for
|
more...
|
4/1/2002
|
$1,598.00
|
|
Blood Disorders Market Analysis & Forecasts Report to 2013
By: Visiongain
In 2007, blood diseases cost the US’s economy $114bn. In 2004, a reported 232,000 deaths in the US were due to anaemia, myeloproliferative and myelodysplastic disorders, bleeding disorders, white blood cell disorders and thrombosis collectively.
|
more...
|
4/14/2008
|
$2,210.00
|
|
BREW: Applications, Markets & Forecasts 2005-2010
By: Visiongain
Are you aware that almost 10% of all handsets shipped are BREW compatible? and that the number of application downloads is now exceeding 200 million?
At the beginning of 2005, 37 wireless operators were
|
more...
|
3/1/2005
|
$2,210.00
|
|
Title
|
Published
|
Price
|
(0 items)
